| 000 | 01580 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250518062548.0 | ||
| 264 | 0 | _c20200224 | |
| 008 | 202002s 0 0 eng d | ||
| 022 | _a1364-5528 | ||
| 024 | 7 |
_a10.1039/c9an00771g _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHeap, Rachel E | |
| 245 | 0 | 0 |
_aProfiling embryonic stem cell differentiation by MALDI TOF mass spectrometry: development of a reproducible and robust sample preparation workflow. _h[electronic resource] |
| 260 |
_bThe Analyst _cOct 2019 |
||
| 300 |
_a6371-6381 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzamides _xpharmacology |
| 650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aDiphenylamine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aEmbryonic Stem Cells _xmetabolism |
| 650 | 0 | 4 | _aHEK293 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 | _aPrincipal Component Analysis |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aPyridines _xpharmacology |
| 650 | 0 | 4 |
_aPyrimidines _xpharmacology |
| 650 | 0 | 4 | _aSpecimen Handling |
| 650 | 0 | 4 |
_aSpectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization _xmethods |
| 650 | 0 | 4 | _aWorkflow |
| 700 | 1 | _aSegarra-Fas, Anna | |
| 700 | 1 | _aBlain, Alasdair P | |
| 700 | 1 | _aFindlay, Greg M | |
| 700 | 1 | _aTrost, Matthias | |
| 773 | 0 |
_tThe Analyst _gvol. 144 _gno. 21 _gp. 6371-6381 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1039/c9an00771g _zAvailable from publisher's website |
| 999 |
_c30156769 _d30156769 |
||